Rhoen-Klinikum AG
RHKJF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.22 | 0.35 | -3.90 | 0.02 |
| FCF Yield | 6.94% | 6.57% | 0.22% | 1.96% |
| EV / EBITDA | 5.67 | 5.53 | 9.46 | 10.36 |
| Quality | ||||
| ROIC | 2.61% | 2.36% | 2.03% | 2.41% |
| Gross Margin | 10.77% | 11.69% | 69.12% | 11.48% |
| Cash Conversion Ratio | 2.82 | 2.82 | 2.40 | 3.56 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.33% | 2.92% | 2.06% | 6.86% |
| Free Cash Flow Growth | 23.81% | 2,100.00% | -89.34% | 20.86% |
| Safety | ||||
| Net Debt / EBITDA | -1.07 | -0.48 | 0.75 | 0.33 |
| Interest Coverage | 14.16 | 10.92 | 8.81 | 9.54 |
| Efficiency | ||||
| Inventory Turnover | 38.01 | 44.77 | 13.40 | 12.99 |
| Cash Conversion Cycle | 88.28 | 72.97 | 54.26 | 27.02 |